Alkermes plc. (ALKS): Shareholders' Equity
$1.82B
As of 2025-12-31
$1.81B
As of 2026-06-30
+20.3%
3-year compound annual growth
+11.3%
5-year compound annual growth
+3.3%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.82B | +24.2% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $1.46B | +21.8% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $1.20B | +15.2% | 2026-02-25, Balance as of period end |
| 2022-12-31 | $1.04B | -6.2% | 2025-02-12, Balance as of period end |
| 2021-12-31 | $1.11B | +4.3% | 2024-02-21, Balance as of period end |
| 2020-12-31 | $1.07B | -1.7% | 2023-02-16, Balance as of period end |
| 2019-12-31 | $1.09B | -7.3% | 2022-02-16, Balance as of period end |
| 2018-12-31 | $1.17B | -2.6% | 2021-02-11, Balance as of period end |
| 2017-12-31 | $1.20B | -0.6% | 2020-02-13, Balance as of period end |
| 2016-12-31 | $1.21B | -8.0% | 2019-02-15, Balance as of period end |
| 2015-12-31 | $1.31B | -5.9% | 2018-02-16, Balance as of period end |
| 2014-12-31 | $1.40B | +31.1% | 2017-02-17, Balance as of period end |
| 2013-12-31 | $1.07B | n/a | 2016-02-25, Balance as of period end |
| 2013-03-31 | $952.37M | +11.5% | 2015-02-24, Balance as of period end |
| 2012-03-31 | $853.85M | +117.8% | 2013-05-23, Balance as of period end |
| 2011-03-31 | $392.02M | -5.0% | 2013-05-23, Balance as of period end |
| 2010-03-31 | $412.62M | n/a | 2012-05-18, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Alkermes plc. (ALKS) | 2025-12-31 | $1.82B | +24.2% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $385.48M | +34.9% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | -$205.31M | n/m |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | -$98.00M | n/m |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.89B | +2.9% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.23B | +67.5% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $1.14B | -25.3% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $602.69M | -20.1% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $489.09M | -16.9% |
Compare ALKS, PAHC, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗